I built this matrix by mapping each row to the single trial endpoint that produced the highest-quality primary evidence as of mid-2026: percent body-weight change for efficacy (Jastreboff 2023, SURMOUNT-1, STEP 1), three-point MACE for cardiovascular (SELECT), MRI-PDFF for hepatic fat (retatrutide Phase 2 sub-analyses, [unverified primary source]), and treatment-emergent adverse event rates for GI burden
Vitamin E oil, usually used in lip care products, has humectant properties that hydrate, and emollient properties, which support the skin barrier
Support weight loss in a short time
To view a copy of this licence, visit About this article Cite this article Mousavi, A., Shojaei, S., Soleimani, H
Each in Phase 2
Drugs like tirzepatide and semaglutide have demonstrated promising clinical outcomes in many patients